OraSure Gets Boost From Abbvie HCV Deal
This article was originally published in The Gray Sheet
Executive Summary
OraSure has granted Abbvie exclusive rights to co-promote its OraQuick HCV rapid test with the pharma firm’s upcoming HCV combination drug therapy.